Ari Robicsek, M.D.

Chief Medical Analytics Officer, Providence St. Joseph Health

Ari Robicsek, M.D.
Ari Robicsek, M.D.

The Difficult Journey to Value: A Roadmap for Success
Tuesday, Nov. 19, 2019 • 8:45 AM–10:00 AM

Ari Robicsek, MD, chief medical analytics officer at Providence St. Joseph Health (PSJH), leads the health system’s Value-Oriented Architecture (VOA) initiative, a groundbreaking effort using sophisticated data science to identify patterns in care delivery that improve quality, efficiency, and consistency. The intent is to help physicians and other caregivers identify areas where they can improve their cost per case and achieve better outcomes.

Dr. Robicek, who specializes in infectious diseases, has a longstanding passion for data science and health care informatics. Before coming to PSJH, he was vice president of clinical analytics at NorthShore University Healthsystem in Evanston, Illinois, where his team received multiple honors for information technology, including placing first in the 2013 Healthcare Informatics Innovator Awards, ranking in the 2014 Information Week Elite 100, being named to the 2016 CIO Magazine Chief Information Officer 100, and leading his health system to become the first in the country to earn ambulatory HIMSS Analytics Stage 7. In 2017, he was one of Health Data Management’s Top 25 Physician IT leaders.

Eager to share his profound knowledge of microbiology, data technology and value-oriented care, Dr. Robicek is a widely-requested speaker at national conferences, including HIMSS and the New England Journal of Medicine Catalyst Conference. He is the author or co-author of more than 65 studies for academic publications, the recipient of numerous prestigious research grants, and a former clinical associate professor at the University of Chicago Pritzker School of Medicine and assistant professor at Northwestern University Feinberg School of Medicine.

Dr. Robicek received his medical degree from the University of Toronto Medical School, where he also served his internship and residency.  He completed a fellowship in infectious diseases at Harvard Medical School.